Therapix Bioscience, Ltd. (NASDAQ: TRPX) Jumps 40% After LOI to Merge with Destiny Biosciences Global Corp.

Therapix Bioscience, Ltd. (NASDAQ: TRPX) operates as a clinical-stage pharmaceutical company, which is focused on developing a pipeline and assets based on cannabinoid-based pharmaceutical treatments. The Israeli cannabis pharma developer currently has tetrahydrocannabinol- (THC) and CannAmide-based drug development programs. Shares of the cannabinoid pharmaceutical developer are jumping 40%, through afternoon trading on Tuesday, July 23, 2019. Over the past three…

Read More

AXIM Biotechnologies, Inc. (OTCQB: AXIM) Rallies 26.56% After Receiving Purchase Order For 50,000 Boxes of Its Proprietary CBD-Based Chewing Gum

AXIM Biotechnologies, Inc.

AXiM Biotechnologies, Inc. (OTCQB: AXIM) is engaged within the research, development, and commercialization of cannabinoid-based pharmaceutical and nutraceutical products. Shares of the cannabis-based treatment company jumped 26.56% during trading on Tuesday, April 23, 2019. Over the past month, AXIM Biotechnologies has seen average daily volume of 166,590 shares. However, volume of 357,235 shares or dollar volume of $578,720, exchanged hands…

Read More